Physician profile
Amna Batool
NPI 1952751703
$2,000.59
in general payments reported to CMS, 2019-2025
18 companies · $606 in 2025
The $606 reported for 2025 was less than what a typical Rheumatology provider received nationally (typical 2025 total: $894).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $350 · 2022: $471 · 2023: $339 · 2024: $234 · 2025: $606.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,067 · Education: $113.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,067.09 |
| Education | $112.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $789.41 | 2021-2025 | Rinvoq, Humira, Skyrizi |
| Novartis Pharmaceuticals Corporation | $300.11 | 2021-2025 | |
| Janssen Biotech, INC. | $268.11 | 2021-2025 | Tremfya |
| Astrazeneca Pharmaceuticals Lp | $138.82 | 2021-2022 | |
| Amgen INC. | $129.25 | 2021-2025 | Krystexxa, Otezla, Tavneos |
| Ucb, INC. | $71.58 | 2022-2023 | Cimzia |
| E.R. Squibb & Sons, L.L.C. | $53.01 | 2024-2025 | Orencia |
| Alexion Pharmaceuticals, INC. | $42.39 | 2025 | Strensiq |
| Mallinckrodt Hospital Products INC. | $39.18 | 2023 | Acthar |
| Pfizer INC. | $34.02 | 2023-2024 | |
| Ani Pharmaceuticals, INC. | $23.99 | 2023 | Purified Cortrophin Gel |
| Horizon Therapeutics Plc | $19.06 | 2021 | |
| Lilly USA, LLC | $16.71 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $15.74 | 2022 | |
| Actelion Pharmaceuticals US, INC. | $15.61 | 2021 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Fresenius Kabi USA, LLC | $15.23 | 2023 | Idacio |
| Glaxosmithkline, LLC. | $14.85 | 2025 | Benlysta |
| Radius Health, INC. | $13.52 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amna Batool listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.